Jorge Adrian Masso-Silva ^1* Gary Lee Bowlin ²

• ¹ University of California, San Diego, La Jolla, United States
• ² Department of Biomedical Engineering, University of Memphis, Memphis, Tennessee, United States

increased survival rates. The study underscores how insufficient clearance of neutrophil extracellular traps (NETs) can exacerbate sepsis severity, particularly with Gram-negative bacteria. By combining DNase1 with antibiotics, this research proposes a novel treatment strategy for sepsis that targets both the pathogens and the harmful immune response generated by the host. (3). Furthermore, another study focused specifically on sepsis-associated ARDS, where they assessed a specific neutrophil population characterized for the expression of CD16 bright and CD62L dim previously found to be immunosuppressive (4). Here, Zhang et al. evaluated the changes of this population in patients with sepsis-associated ARDS, where they found that this neutrophil population is elevated in these patients and is associated with poor prognosis, suggesting their use as predictors for future clinical complications (5). Altogether, this area of study get us closer to better understanding the status of sepsis and sepsis-associated ARDS in the context of the contribution of neutrophils to illness severity and how we could potentially employ more effective therapies to these patients based on their neutrophil phenotypes, where future clinical studies could investigate whether the combination therapies such as DNase1 together with specific antibiotics could be a breakthrough in the management of sepsis.Fever and hypothermia represent two opposing physiological responses to systemic inflammation. Fever stimulates immune activation, while hypothermia promotes energy conservation. Both conditions are significant in the context of Systemic Inflammatory Response Syndrome (SIRS), a major cause of mortality worldwide. A crucial component of the body's defense against infection is the neutrophils, which release NETs to capture and eliminate pathogens. Recent research by Janko et al. examined how temperature affects the kinetics of NET release, which is directly linked to enzyme activity and their degradation. The study discovered that NET formation increased at 40°C; however, responses were reduced at both 35°C and 42°C. Interestingly, the degradation of NETs was enhanced at higher temperatures, likely due to increased activity of plasma DNase. These findings indicate that temperature plays a critical role in regulating the release and degradation of neutrophil NETs. Overall, this research could pave the way for new therapeutics aimed at modulating immune responses in conditions like SIRS, pending further clinical testing and validation (6).Without a doubt, the study of neutrophil heterogeneity at a single cell resolution has helped to now recognize neutrophils as a heterogenous population, which was not the case 20 years ago, when NETs were discovered in 2004 (7). The use of single-cell RNA-seq (scRNA-seq) analyses has allowed us to define neutrophil diversity in homeostasis and disease in anatomical compartments where usually neutrophils are not studied in depth. An example is the study performed by Villagómez-Olea et al., on the periodontal ligament, which contains significant cellular heterogeneity, including the presence of neutrophils. Using scRNA-seq, they identified 4 distinct neutrophil populations, and interestingly, all these populations seem to represent different stages of neutrophil undergoing maturation. Hence, authors suggest that the periodontal ligament can serve as a niche where neutrophils can mature, serving to some extent as a place for granulopoiesis (8). Although extramedullary hematopoiesis is generally a compensatory mechanism in response to bone marrow dysfunction or increased demand for blood cells (mostly during inflammation), it is not a regular site of granulopoiesis in healthy adults (9). Thus, this study may uncover a niche where extramedullary granulopoiesis can occur in homeostatic conditions.In summary, this collection includes studies addressing neutrophil heterogeneity defined by different methodologies, such as cell surface markers, functionality, and scRNA-seq, providing key insights into different physiological conditions. Nevertheless, there are still many challenges in understanding neutrophil heterogeneity. Although, with the rise of single-cell technologies, we now have the opportunity to better define the heterogeneity of neutrophils in-depth, that in combination with longitudinal studies, we could better understand them under homeostasis and disease over time to define key cellular and molecular changes, aiming for better therapies targeting neutrophils when is most needed.Bibliography: